AI wound analysis market seen topping $2.28 billion by 2030

The Business Research Company says the AI-enabled wound analysis market will grow from $1.17 billion in 2025 to $1.34 billion in 2026, then reach $2.28 billion by 2030. The report points to personalized medicine, remote monitoring and telehealth as key forces reshaping wound care workflows.

Why it matters: - AI-enabled wound analysis is moving from a niche digital tool to a broader healthcare workflow that can improve wound measurement, monitoring and treatment decisions. - The market’s growth reflects demand for faster, more standardized wound care as clinicians manage more chronic wounds and diabetic ulcers. - The technology could support remote care models and reduce some of the burden of manual assessments in busy clinical settings.

What happened: - The Business Research Company published a 2026 market report on AI-enabled wound analysis covering market size, trends and global forecasts through 2035. - The report estimates the market will grow from $1.17 billion in 2025 to $1.34 billion in 2026, a 14.1% compound annual growth rate. - The report projects the market will reach $2.28 billion by 2030, with a 14.3% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region in the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa.

The details: - AI-enabled wound analysis uses machine learning, computer vision and digital imaging to evaluate, monitor and manage wounds. - The technology measures wound size, classifies tissue types, tracks healing progress and flags early signs of complications. - The report links market growth to rising use of remote patient monitoring, home healthcare, AI-enhanced diagnostic imaging and telemedicine in wound management. - Predictive clinical analytics and computer vision advances are also listed as growth drivers. - The report highlights growth in remote wound monitoring, telehealth services, AI-driven severity grading, automated chronic wound management platforms, clinical decision support systems and predictive analytics. - Personalized medicine is identified as a major growth driver because AI wound tools can help tailor treatment plans to wound size, depth, tissue composition and infection risk. - The Personalized Medicine Coalition reported in February 2024 that more than one-third of new FDA drug approvals over the prior four years were personalized therapies. - The FDA approved 16 treatments for rare diseases in 2023, compared with six in 2022. - The FDA also approved seven oncology drugs and three drugs for other conditions in 2023. - The report says expanded use of genomic data is accelerating adoption of personalized medicine and supporting demand for AI-enabled wound analysis. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The report offers a free sample and the full report through the company's announcement and the full market report.

Between the lines: - The forecast suggests AI wound analysis is gaining traction because it sits at the intersection of digital health, diagnostics and personalized medicine. - The strongest near-term opportunity appears to be in tools that extend wound care beyond the hospital, especially remote monitoring and home-based treatment. - The report’s emphasis on analytics and decision support points to a market that is competing on clinical workflow integration, not just image recognition.

What's next: - The market is expected to keep expanding through 2030 as telemedicine, home healthcare and AI-based diagnostic imaging become more embedded in wound care. - The report expects continued development of severity grading systems, chronic wound management platforms and predictive tools that estimate healing trajectories. - Regional growth will likely remain strongest outside North America, with Asia-Pacific positioned for the fastest expansion.